Janus Henderson Group PLC Has $579.58 Million Position in athenahealth, Inc. (ATHN)

Janus Henderson Group PLC decreased its position in shares of athenahealth, Inc. (NASDAQ:ATHN) by 8.2% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 4,660,471 shares of the health services provider’s stock after selling 418,550 shares during the quarter. Janus Henderson Group PLC owned approximately 11.65% of athenahealth worth $579,576,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Turner Investments LLC purchased a new stake in athenahealth in the 2nd quarter worth $105,000. Bessemer Group Inc. lifted its stake in athenahealth by 13.7% in the 2nd quarter. Bessemer Group Inc. now owns 938 shares of the health services provider’s stock worth $132,000 after purchasing an additional 113 shares in the last quarter. The Manufacturers Life Insurance Company lifted its stake in athenahealth by 7.7% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock worth $166,000 after purchasing an additional 84 shares in the last quarter. BNP Paribas Arbitrage SA lifted its stake in athenahealth by 123.8% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 1,345 shares of the health services provider’s stock worth $189,000 after purchasing an additional 744 shares in the last quarter. Finally, ProShare Advisors LLC purchased a new stake in athenahealth in the 2nd quarter worth $205,000.

Several brokerages have commented on ATHN. Leerink Swann set a $155.00 price target on shares of athenahealth and gave the stock a “hold” rating in a research note on Thursday, October 19th. BidaskClub upgraded shares of athenahealth from a “strong sell” rating to a “sell” rating in a report on Saturday, December 2nd. Jefferies Group set a $110.00 target price on shares of athenahealth and gave the stock a “hold” rating in a report on Friday, October 13th. Robert W. Baird reduced their target price on shares of athenahealth from $170.00 to $155.00 and set an “outperform” rating on the stock in a report on Sunday, October 22nd. Finally, Cantor Fitzgerald restated a “hold” rating and issued a $145.00 target price on shares of athenahealth in a report on Friday, October 20th. Two investment analysts have rated the stock with a sell rating, fourteen have given a hold rating and eleven have issued a buy rating to the company. athenahealth presently has a consensus rating of “Hold” and a consensus price target of $143.22.

athenahealth, Inc. (NASDAQ ATHN) opened at $135.55 on Friday. The company has a market cap of $5,356.37, a PE ratio of 113.43, a P/E/G ratio of 5.02 and a beta of 1.57. athenahealth, Inc. has a fifty-two week low of $90.11 and a fifty-two week high of $158.66. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.35.

athenahealth (NASDAQ:ATHN) last issued its quarterly earnings results on Thursday, October 19th. The health services provider reported $0.56 EPS for the quarter, beating the consensus estimate of $0.50 by $0.06. The company had revenue of $304.60 million for the quarter, compared to the consensus estimate of $310.52 million. athenahealth had a net margin of 2.65% and a return on equity of 6.78%. The firm’s revenue was up 10.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.60 EPS. equities analysts predict that athenahealth, Inc. will post 1.2 earnings per share for the current fiscal year.

In related news, CEO Jonathan Bush sold 4,000 shares of the company’s stock in a transaction dated Monday, October 2nd. The shares were sold at an average price of $124.17, for a total transaction of $496,680.00. Following the transaction, the chief executive officer now directly owns 319,807 shares in the company, valued at approximately $39,710,435.19. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Jonathan D. Porter sold 300 shares of the company’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $130.38, for a total transaction of $39,114.00. The disclosure for this sale can be found here. Insiders have sold a total of 9,283 shares of company stock worth $1,175,908 over the last quarter. 3.20% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY WARNING: This report was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this report on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The original version of this report can be read at https://www.dispatchtribunal.com/2017/12/08/janus-henderson-group-plc-has-579-58-million-position-in-athenahealth-inc-athn.html.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply